Windtree Therapeutics Files 8-K Report
Ticker: WINTW · Form: 8-K · Filed: Apr 23, 2024 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Corporate Reporting
Related Tickers: WINT
TL;DR
WINT filed an 8-K, mostly standard stuff, check exhibits for details.
AI Summary
On April 23, 2024, Windtree Therapeutics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements and exhibits. No specific financial figures or significant events beyond routine reporting were detailed in the provided excerpt.
Why It Matters
This filing indicates routine corporate reporting activity for Windtree Therapeutics, Inc. to the SEC.
Risk Assessment
Risk Level: low — The filing appears to be a routine 8-K with no immediate negative or positive financial disclosures or significant events mentioned.
Key Numbers
- 001-39290 — SEC File Number (Identifies the company's filing with the SEC.)
- 94-3171943 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Warrington, Pennsylvania (location) — Principal executive offices
FAQ
What specific 'Other Events' are detailed in this 8-K filing?
The provided excerpt does not specify the 'Other Events'; it only lists 'Other Events' as an item information category.
Are there any significant financial statements or exhibits attached to this filing?
The filing indicates 'Financial Statements and Exhibits' as an item information category, but the specific content of these is not detailed in the excerpt.
What is the principal executive office address for Windtree Therapeutics, Inc.?
The principal executive offices are located at 2600 Kelly Road, Suite 100, Warrington, Pennsylvania 18976.
When was Windtree Therapeutics, Inc. incorporated?
The company was incorporated in Delaware.
What is the SIC code for Windtree Therapeutics, Inc.?
The Standard Industrial Classification code is 2836, for Biological Products (No Diagnostic Substances).
Filing Stats: 460 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-04-23 17:09:59
Key Financial Figures
- $0.001 — h registered Common Stock , par value $0.001 per share WINT The Nasdaq Capital Ma
Filing Documents
- wint20240423_8k.htm (8-K) — 25KB
- ex_659059.htm (EX-99.1) — 19KB
- slide01.jpg (GRAPHIC) — 118KB
- slide02.jpg (GRAPHIC) — 267KB
- slide03.jpg (GRAPHIC) — 182KB
- slide04.jpg (GRAPHIC) — 192KB
- slide05.jpg (GRAPHIC) — 148KB
- slide06.jpg (GRAPHIC) — 123KB
- slide07.jpg (GRAPHIC) — 177KB
- slide08.jpg (GRAPHIC) — 193KB
- slide09.jpg (GRAPHIC) — 116KB
- slide10.jpg (GRAPHIC) — 149KB
- slide11.jpg (GRAPHIC) — 142KB
- slide12.jpg (GRAPHIC) — 147KB
- slide13.jpg (GRAPHIC) — 109KB
- slide14.jpg (GRAPHIC) — 160KB
- slide15.jpg (GRAPHIC) — 98KB
- slide16.jpg (GRAPHIC) — 116KB
- slide17.jpg (GRAPHIC) — 138KB
- slide18.jpg (GRAPHIC) — 116KB
- slide19.jpg (GRAPHIC) — 156KB
- slide20.jpg (GRAPHIC) — 173KB
- slide21.jpg (GRAPHIC) — 202KB
- slide22.jpg (GRAPHIC) — 106KB
- slide23.jpg (GRAPHIC) — 155KB
- slide24.jpg (GRAPHIC) — 168KB
- slide25.jpg (GRAPHIC) — 74KB
- slide26.jpg (GRAPHIC) — 220KB
- slide27.jpg (GRAPHIC) — 206KB
- slide28.jpg (GRAPHIC) — 239KB
- slide29.jpg (GRAPHIC) — 225KB
- slide30.jpg (GRAPHIC) — 136KB
- 0001437749-24-012871.txt ( ) — 6710KB
- wint-20240423.xsd (EX-101.SCH) — 3KB
- wint-20240423_def.xml (EX-101.DEF) — 11KB
- wint-20240423_lab.xml (EX-101.LAB) — 15KB
- wint-20240423_pre.xml (EX-101.PRE) — 11KB
- wint20240423_8k_htm.xml (XML) — 3KB
01
Item 8.01 Other Events. On April 23, 2024, Windtree Therapeutics, Inc. (the "Company") updated information reflected in a slide presentation, which is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Representatives of the Company will use the updated presentation in various meetings with investors from time to time.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed herewith: Exhibit No. Document 99.1 Corporate Presentation of Windtree Therapeutics, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: April 23, 2024 Windtree Therapeutics, Inc. By: /s/ Craig E. Fraser Name: Craig E. Fraser Title: President and Chief Executive Officer